Skip to main content

Table 5 Costs of attacks treated in compliance with the strategies

From: Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

 

Strategy 1 (home-based)

Strategy 2 (hospital-based)

Savings per attack

Total

Per patient (N = 31)

Per attack (N = 497)

Total

Per patient (N = 8)

Per attack (N = 26)

 

Medical costs (€)

Drug cost

608,399.00

19,625.77

1224.14

37,319.00

4664.88

1435.35

 

ED visits

0

0

0

483.34

60.42

18.59

 

Total

608,399.00

19,625.77

1224.14

37,802.34

4725.29

1453.94

 

Non-medical costs (€)

Missed work/school days

13,737.47

443.14

27.64

5071.65

633.96

195.06

 

Travel expenses

0

0

0

39.74

4.97

1.53

 

Total

13,737.47

443.14

27.64

5111.39

638.92

196.59

 

Payer perspective (€)

608,399.00

19,625.77

1224.14

37,802.34

4725.29

1453.94

229.8

Societal perspective (€)

622,136.47

20,068.92

1251.78

42,913.73

5364.22

1650.53

398.74